CTNM
Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ · USHealthcareBiotechnology
$14.02-1.48%
Price as of Jul 20, 2026
CTNM ownership
Contineum Therapeutics, Inc. Class A Common Stock ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
10
Net (3m)
-$1.1M
Insider trades by month Buys Sells
Feb
Mar
Apr
May
Jun
Jul
Context3-month price +19%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 10, 2026 | Lorrain Daniel S.officer: Chief Scientific Officer | Option | 1,015 | $1.01 |
| Jul 10, 2026 | Lorrain Daniel S.officer: Chief Scientific Officer | Option | 25 | $1.01 |
| Jul 10, 2026 | Lorrain Daniel S.officer: Chief Scientific Officer | Sell | 25 | $16.00 |
| Jul 8, 2026 | Stengone Carmine N.director, officer: CEO and President | Sell | 2,500 | $16.00 |
| Jul 8, 2026 | Stengone Carmine N.director, officer: CEO and President | Option | 2,500 | $1.01 |
| Jul 2, 2026 | Lorrain Daniel S.officer: Chief Scientific Officer | Option | 28,826 | $1.01 |
| Jul 2, 2026 | Lorrain Daniel S.officer: Chief Scientific Officer | Sell | 2,501 | $16.24 |
| Jul 2, 2026 | Lorrain Daniel S.officer: Chief Scientific Officer | Sell | 5,852 | $15.67 |
| Jul 2, 2026 | Lorrain Daniel S.officer: Chief Scientific Officer | Option | 4,183 | $1.01 |
| Jul 2, 2026 | Lorrain Daniel S.officer: Chief Scientific Officer | Sell | 28,826 | $16.04 |
| Jul 1, 2026 | Watkins Timofficer: CMO & Head of Development | Option | 10,833 | $4.50 |
| Jul 1, 2026 | Stengone Carmine N.director, officer: CEO and President | Sell | 10,000 | $16.01 |
| Jul 1, 2026 | Stengone Carmine N.director, officer: CEO and President | Option | 2,500 | $1.26 |
| Jul 1, 2026 | Stengone Carmine N.director, officer: CEO and President | Option | 7,500 | $1.01 |
| Jul 1, 2026 | Watkins Timofficer: CMO & Head of Development | Sell | 10,833 | $16.02 |
| Jun 26, 2026 | Miralles Gines Diegodirector | Grant | 19,000 | $14.19 |
| Jun 26, 2026 | Boyce Sarahdirector | Grant | 19,000 | $14.19 |
| Jun 26, 2026 | Brady Todd R.director | Grant | 19,000 | $14.19 |
| Jun 26, 2026 | Ignelzi Troy A.director | Grant | 19,000 | $14.19 |
| Jun 26, 2026 | Schimmelpennink Evert B.director | Grant | 19,000 | $14.19 |
| Jun 26, 2026 | Ware Olivia Cdirector | Grant | 19,000 | $14.19 |
| Jun 26, 2026 | Lyons-Williams Loridirector | Grant | 19,000 | $14.19 |
| Jun 1, 2026 | Lorrain Daniel S.officer: Chief Scientific Officer | Sell | 4,170 | $13.16 |
| May 1, 2026 | Lorrain Daniel S.officer: Chief Scientific Officer | Sell | 3,870 | $13.06 |
| May 1, 2026 | Lorrain Daniel S.officer: Chief Scientific Officer | Sell | 300 | $13.84 |
| Apr 6, 2026 | Lorrain Daniel S.officer: Chief Scientific Officer | Sell | 4,170 | $13.43 |
| Mar 2, 2026 | Watkins Timofficer: CMO & Head of Development | Option | 3,611 | $4.50 |
| Mar 2, 2026 | Watkins Timofficer: CMO & Head of Development | Sell | 3,611 | $15.02 |
| Mar 2, 2026 | Lorrain Daniel S.officer: Chief Scientific Officer | Sell | 4,170 | $15.01 |
| Feb 26, 2026 | Stengone Carmine N.director, officer: CEO and President | Sell | 4,400 | $16.02 |
Source: CTNM SEC Form 4 filings, latest Jul 10, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their CTNM positions over the last 6 months (SEC Form 13F).
Increased
63
New positions
49
Reduced
31
Sold out
22
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | Unchanged | 2.8M | May 15, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Increased | 2.8M | Feb 17, 2026 |
| JANUS HENDERSON GROUP PLC | Increased | 2.7M | May 18, 2026 |
| JANUS HENDERSON GROUP PLC | New Position | 2.4M | Feb 17, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Increased | 2.2M | Feb 17, 2026 |
| JOHNSON & JOHNSON | Reduced | 2.0M | May 13, 2026 |
| JOHNSON & JOHNSON | Unchanged | 2.0M | Mar 18, 2026 |
| FRANKLIN RESOURCES INC | Increased | 1.9M | Feb 11, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Increased | 1.8M | Feb 17, 2026 |
| FRANKLIN RESOURCES INC | Reduced | 1.8M | May 13, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Reduced | 1.7M | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 1.5M | May 15, 2026 |
| PERCEPTIVE ADVISORS LLC | Increased | 1.5M | Feb 17, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 1.4M | May 15, 2026 |
| BAKER BROS. ADVISORS LP | Increased | 1.4M | Feb 17, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.